Gossamer Bio Reports Final Results for Convertible Note Exchange Offer
Gossamer Bio, Inc. has released the final tender results for its exchange offer involving convertible senior notes. The offer allowed holders to swap existing 2027 notes for new 2030 secured notes, common stock, or prefunded warrants. This financial maneuver aims to restructure the company's debt and equity profile.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.